Step Towards a Better Understanding of Multiple Sclerosis
DNA-binding factor called TOX plays a role in triggering multiple sclerosis. TOX license immune cells to cause autoimmune tissue destruction in the brain.
DNA-binding factor called TOX plays a role in triggering multiple sclerosis. TOX license immune cells to cause autoimmune tissue destruction in the brain.
‘On the Open Trial Selective Reminding Test, all participants were identified as impaired, while only 34 percent were similarly identified on the California Verbal Learning Test.’
Tweet it Now
Researchers administered the tests to 112 individuals with MS, 79 women and 33 men. Results showed clear differences in performance on the California Verbal Learning Test (CVLT-II) and the Open Trial Selective Reminding Test (OT-SRT). On the OT-SRT, all participants were identified as impaired, while only 34 percent were similarly identified on the CLV-TII. Differences in administration of the tests may explain this disparity. With the OT-SRT learning and memory are tested with minimal reliance on other cognitive abilities. With the CVLTII, reliance on other cognitive abilities is more prominent, likely affecting the testing results. "It is essential that the neuropsychological assessment accurately pinpoint the deficits in MS," said Dr. Costa, the lead author. "This is fundamental to developing interventions to address these deficits, and tailoring cognitive rehabilitation programs for maximal outcomes in this population."
New study by Kessler Foundation compared two neuropsychological tests for assessing learning in individuals with multiple sclerosis (MS). The article, "Comparing the Open Trial - Selective Reminding Test results with the California Learning Verbal Test II in Multiple Sclerosis" is published in Applied Neuropsychology: Adult.
Spinal Fluid Could be Used to Predict the Progression of Multiple Sclerosis
Analysis of fluid in the spine could be used to predict the future progression of multiple sclerosis, revealed research.
Analysis of fluid in the spine could be used to predict the future progression of multiple sclerosis, revealed research.
Researchers administered the tests to 112 individuals with MS, 79 women and 33 men. Results showed clear differences in performance on the California Verbal Learning Test (CVLT-II) and the Open Trial Selective Reminding Test (OT-SRT). On the OT-SRT, all participants were identified as impaired, while only 34 percent were similarly identified on the CLV-TII. Differences in administration of the tests may explain this disparity. With the OT-SRT learning and memory are tested with minimal reliance on other cognitive abilities. With the CVLTII, reliance on other cognitive abilities is more prominent, likely affecting the testing results.
Advertisement
Multiple Sclerosis Patients can Now be Monitored Better With Algorithms
With the new algorithm in place patients with multiple sclerosis can be monitored better clinically with wearable sensors finds a new study.
With the new algorithm in place patients with multiple sclerosis can be monitored better clinically with wearable sensors finds a new study.
Advertisement
New Discovery may Open Up New Treatments for Multiple Sclerosis
Study identifies the overabundance of a particular protein in the brains of people with multiple sclerosis.
Study identifies the overabundance of a particular protein in the brains of people with multiple sclerosis.
